×
The Standard e-Paper
Join Thousands Daily
The Standard Group Plc is a
multi-media organization with investments in media platforms spanning newspaper
print operations, television, radio broadcasting, digital and online services. The
Standard Group is recognized as a leading multi-media house in Kenya with a key
influence in matters of national and international interest.
Developed by Danish drugmaker Novo Nordisk, and FDA-approved in 2017, Ozempic lowers blood sugar by helping the body make more insulin through weekly injections.
Its main aim is to help adults who suffer from type 2 diabetes to manage their blood sugar. They use semaglutide to mimic a naturally occurring hormone, which communicates to the brain that you are full. The chemical also slows digestion, increasing how long food should process and leave the body.
Subscribe to our newsletter and stay updated on the latest developments and special offers!
Prefer the Standard on Google
join